DrugPatentWatch Database Preview
Litigation Details for ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. )
ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. )
| Docket | Start Trial | Date Filed | |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | ||
| Patents | 6,455,557 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ACORDA THERAPEUTICS, INC. v. APOTEX INC.
The small molecule drug covered by the patent cited in this case is Start Trial .
Details for ACORDA THERAPEUTICS, INC. v. APOTEX INC. (D.N.J. )
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2011-09-06 | 281 | Apotex infringes U.S. Patent No. 6,455,557 (“the ‘557 patent”). The patent is directed generally to… to reduce somnolence. (U.S. Patent No. 6,455,557 (“the ‘557 patent”) at 14:8-34). However, the … Finds that the Patent Claims Involve Patentable Subject Matter The Patent Act provides “[w…557 patent claims patentable subject matter. Apotex proceeds on the premise that the patented methods…49 A. The Court Finds that the Patent Claims Involve Patentable Subject 49 | External link to document | |
| 2008-12-29 | 41 | alleging infringement of its patent, U.S. Patent No. 6,455,557 (“the ’557 patent”). Specifically, in its … “has infringed at least one claim of the ’557 patent by submitting, or causing to be submitted to the…capsules before the expiration date of the ‘557 patent.” (Compl. ¶ 15.) As part of its prayer for relief…attorneys fees under Section 285.” In typical patent infringement cases, the United States Court of … 2:07-cv-04937-GEB-MCA Patent District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
